MicroStrategy
MSTR
Adobe
ADBE
Salesforce
CRM
Apple
AAPL
Meritage Homes
MTH
US Stock MarketDetailed Quotes
AEMD Aethlon Medical
- 0.5800
- +0.1466+33.83%
Close Dec 20 16:00 ET
- 0.5800
- 0.00000.00%
Post 20:01 ET
8.10MMarket Cap-0.21P/E (TTM)
0.8278High0.4780Low71.87MVolume0.5835Open0.4334Pre Close44.52MTurnover518.48%Turnover RatioLossP/E (Static)13.96MShares2.349952wk High1.35P/B8.04MFloat Cap0.237552wk Low--Dividend TTM13.86MShs Float67499.9865Historical High--Div YieldTTM80.71%Amplitude0.2375Historical Low0.6190Avg Price1Lot Size
About Aethlon Medical Company
Aethlon Medical, Inc. is a medical technology company which focuses on developing products to diagnose and treat life and organ threatening diseases. It develops Aethlon Hemopurifier, which is a clinical-stage immunotherapeutic device designed to combat cancer and life-threatening viral infections. The firm operates through the following segments: Aethlon and ESI. The Aethlon segment is involved in therapeutic business activities. The ESI segment consists of diagnostic business activities. The company was founded by James A. Joyce in 1991 and is headquartered in San Diego, CA.
Company Profile
SymbolAEMD
Company NameAethlon Medical
Listing DateJul 13, 2015
Founded1991
CEOMr. James B. Frakes
MarketNASDAQ
Employees14
Fiscal Year Ends03-31
Address11555 Sorrento Valley Road,Suite 203
CitySan Diego
ProvinceCalifornia
CountryUnited States of America
Zip Code92121
Phone1-619-941-0360
Company Executives
- Name
- Position
- Salary
- James B. Frakes
- Director, Chief Financial Officer, Chief Executive Officer and Principal Accounting Officer
- 416.45K
- Dr. Steven P. Larosa, M.D.
- Chief Medical Officer
- 430.00K
- Edward G. Broenniman
- Chairman of the Board
- 147.50K
- Nicolas Gikakis
- Independent Director
- 112.50K
- Dr. Chetan S. Shah, M.D.
- Independent Director
- 113.75K
- Angela Rossetti
- Independent Director
- 113.00K
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
